Part 8: Advanced challenges in resuscitation - Section 2: Toxicology in ECC

Resuscitation

Volumn 46, Issue 1-3, 2000, Pages 261-266

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ATROPINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; BRETYLIUM TOSYLATE; CARDIAC GLYCOSIDE; COCAINE; DIGITOXIN; DIGOXIN; ESMOLOL; GLYCERYL TRINITRATE; LABETALOL; LIDOCAINE; MAGNESIUM; METOPROLOL; NALMEFENE; NALOXONE; NITROPRUSSIDE SODIUM; OBIDOXIME; OPIATE; ORGANOPHOSPHATE INSECTICIDE; PHENCYCLIDINE; PHENTOLAMINE; PHENYTOIN; PHYSOSTIGMINE; PRALIDOXIME; UNINDEXED DRUG;

BRAIN DEATH; CARDIOTOXICITY; CARDIOVERSION; DEFIBRILLATION; DRUG OVERDOSE; HEART ARREST; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOVOLEMIC SHOCK; INTOXICATION; PRIORITY JOURNAL; RESUSCITATION; REVIEW;

EID: 0034705950     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(00)00287-2     Document Type: Note

References (30)

1. Litovitz T.L., Felberg L., White S., et al. 1995 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 14:1996;487-537.
2. McCaig L.F., Burt C.W. Poisoning-related visits to emergency departments in the United States, 1993-1996. J Toxicol Clin Toxicol. 37:1999;817-826.
3. Fingerhut L.A., Cox C.S. Poisoning mortality, 1985-1995. Public Health Rep. 113:1998;221-235.
4. Facility assessment guidelines for regional toxicology treatment centers. J Toxicol Clin Toxicol. 31:1993;211-217.
5. Poison information and treatment systems. Ann Emerg Med. 28:1996;384.
6. Vale J.A. for the American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position statement: gastric lavage. J Toxicol Clin Toxicol. 35:1997;711-719.
7. Moss S.T., Chan T.C., Buchanan J., et al. Outcome study of prehospital patients signed out against medical advice by field paramedics. Ann Emerg Med. 31:1998;247-250.
8. Vilke G.M., Buchanan J., Dunford J.V., et al. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 3:1999;183-186.
9. Antman E.M., Wenger T.L., Butler V.P. Jr, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicenter study. Circulation. 81:1990;1744-1752.
10. Ramoska E., Sacchetti A.D. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med. 14:1985;1112-1113.
11. Brogan W.C., Lange R.A., Kim A.S., et al. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 18:1991;581-586.
12. Lange R.A., Cigarroa R.G., Clyde W.Y., et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 321:1989;1557-1562.
13. Boehrer J.D., Moliterno D.J., Willard J.E., et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 94:1993;608-610.
14. Lange R.A., Cigarroa R.G., Flores E.D., et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 112:1990;897-903.
15. Gay G.R., Loper K.A. The use of labetalol in the management of cocaine crisis. Ann Emerg Med. 17:1988;282-283.
16. Dusenberry S.J., Hicks M.J., Mariani P.J. Labetalol treatment of cocaine toxicity. Ann Emerg Med. 16:1987;235.
17. Sand C., Brody S.L., Wrenn K.D., et al. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med. 9:1991;161-163.
18. Shih R.D., Hollander J.E., Burstein J.L., et al. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med. 26:1995;702-706.
19. Mayron R., Ruiz E. Phenytoin: does it reverse tricyclic-antidepressant-induced cardiac conduction abnormalities? Ann Emerg Med. 15:1986;876-880.
20. Callaham M., Schumaker H., Pentel P. Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning. J Pharmacol Exp Ther. 245:1988;216-220.
21. Knudsen K., Abrahamsson J. Effects of magnesium sulfate and lidocaine in the treatment of ventricular arrhythmias in experimental amitriptyline poisoning in the rat. Crit Care Med. 22:1994;494-498.
22. Kline J.A., DeStefano A.A., Schroeder J.D., et al. Magnesium potentiates imipramine toxicity in the isolated rat heart. Ann Emerg Med. 24:1994;224-232.
23. Brown T.C.K. Tricyclic antidepressant overdosage: experimental studies on the management of circulatory complications. Clin Toxicol. 9:1976;255-272.
24. Vernon D.D., Banner W. Jr, Garrett J.S. Efficacy of dopamine and norepinephrine for treatment of hemodynamic compromise in amitriptyline intoxication. Crit Care Med. 19:1991;544-549.
25. Love J.N., Leasure J.A., Mundt D.J. A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine model. Am J Emerg Med. 11:1993;360-363.
26. Wolf L.R., Spadafora M.P., Otten E.J. Use of amrinone and glucagon in a case of calcium channel blocker overdose. Ann Emerg Med. 22:1993;1225-1228.
27. Kollef M.H. Labetalol overdose successfully treated with amrinone and alpha-adrenergic receptor agonists. Chest. 105:1994;626-627.
28. Ramsay I.D. Survival after imipramine poisoning. Lancet. 2:1967;1308-1309.
29. Southall D.R., Kilpatrick S.M. Imipramine poisoning: survival of a child after prolonged cardiac massage. BMJ. 4:1974;508.
30. Hebert M.J., Boucher A., Beaugage G., et al. Transplantation of kidneys from donor with carbon monoxide poisoning. N Engl J Med. 326:1992;1571.